Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 18 August 2009, doi:10.1136/bmj.b3352
Cite this as: BMJ 2009;339:b3352
| The first 150 words of the full text of this article appear below. |
Inzitari and colleagues describe the association between white matter changes in older patients and subsequent functional decline.1 Their findings show that new occult markers of disease may exist and reinforce some of the intuition of clinicians dealing with elderly patients, raising some interesting issues.
Firstly, although education conferred a protective effect on subsequent decline, the presence of osteoarthritis conferred stronger protection than a year of education, even when adjusted for other risk factors. The anti-inflammatory effect from the concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) may have conferred some benefit. NSAIDs selective for cyclo-oxygenase-2 (COX 2 inhibitors) increase cardiovascular risk,2 but the evidence of harm from non-selective NSAIDs is limited.3 Indeed, some beneficial effects of non-selective NSAIDs on cognitive decline, albeit contended, have been noted.4 Were data on drug treatment collected? If so, was NSAID use or class of NSAID associated with progression to death or disability? Issues of statistical
David J Robinson, specialist registrar in geriatric medicine1, Diarmuid OShea, consultant physician2
1 Royal Hospital, Donnybrook, Dublin 4, Republic of Ireland, 2 St Vincents University Hospital, Dublin 4
davidjrobinson@iol.ie